Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 737218

Design, Synthesis and in vitro Activity of AT1 Angiotensin II receptor Antagonists Based on the Novel 5-[2-(tetrazole-5- yl)phenyl]thiophenes


Lovrić, Marija; Tvrdeić, Ante; Cepanec, Ivica; Litvić, Mladen
Design, Synthesis and in vitro Activity of AT1 Angiotensin II receptor Antagonists Based on the Novel 5-[2-(tetrazole-5- yl)phenyl]thiophenes // Book of Abstracts 4th Croatian Congress of Neuroscience
Zagreb: Croatian Society for Neuroscience, Croatian Insitute for Brain Research, 2013. str. 73-74 (poster, međunarodna recenzija, sažetak, znanstveni)


CROSBI ID: 737218 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Design, Synthesis and in vitro Activity of AT1 Angiotensin II receptor Antagonists Based on the Novel 5-[2-(tetrazole-5- yl)phenyl]thiophenes

Autori
Lovrić, Marija ; Tvrdeić, Ante ; Cepanec, Ivica ; Litvić, Mladen

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Book of Abstracts 4th Croatian Congress of Neuroscience / - Zagreb : Croatian Society for Neuroscience, Croatian Insitute for Brain Research, 2013, 73-74

Skup
4th Croatian Congress of Neuroscience

Mjesto i datum
Zagreb, Hrvatska, 20-21.09.2013

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
angiotensin II (AII) AT1 receptors; 5-[2-(tetrazole-5-yl)phenyl]thiophenes; sartans

Sažetak
Angiotensin II receptor antagonists, also known as sartans are a new class of pharmacological agents for treatment of hypertension. Despite the structural differences, all commercial sartans characterise the same mechanism on molecular level. They act as selective blockers (antagonists) of the most potent vasoconstrictor, angiotensin II AT1 receptors. A new series of nonpeptide angiotensin II receptor antagonists, structural analogs of sartan, derivatives of 5-[2-(tetrazole-5- yl)phenyl]thiophene is described. Biological activity of the newly synthesised compounds was tested on two in vitro models on glomeruli isolated from rat kidney cortex. Obtained results were compared with the commercially antihypertensive drug known under the generic name valsartan (N-Valeroyl-N-{; ; [2'-(1H- tetrazole-5-yl)[1, 1'-biphenyl]-4-yl]methyl}; ; - L- valine). Replacement of the central phenyl ring of the biphenyl moiety of valsartan with a heteroaromatic thiophene increases the ability of compounds to antagonise the vasoconstriction induced by AII on isolated glomeruli. Heterobiaryl lauroyl derivative (N-lauroyl-N- {; ; 5-[2-(tetrazole-5-yl)phenyl]thiophen-2- yl}; ; methyl-L-valine) act as the most potent blocker and competitive inhibitor on angiotensin II evoked contractile response (KB = 26.3 nmol/dm3) by more than one order of magnitude higher estimated affinity for AT1 receptors than available valsartan (KB = 562.3 nmol/dm3). Heterobiaryl compounds with lengthened aliphatic chain on lipophilic acyl moiety show higher antagonism effect. The new compounds were examined for binding affinity to AT1 receptor on glomeruli using radioactive labelled angiotensin II ([3H]AII) as radioligand. Replacement of the central phenyl ring of the biphenyl moiety of valsartan with a heteroaromatic thiophene decreases the binding affinity and inhibitory effect of the compounds. Heterobiaryl valeroyl derivative (N- valeroyl-N-{; ; 5-[2-(tetrazole-5- yl)phenyl]thiophen-2-yl}; ; methyl-L-valine, Ki = 525.2 nmol/dm3) and lauroyl derivative (Ki = 563.1 nmol/dm3) show the highest binding affinity, but still two orders of magnitude lower than valsartan (Ki = 4.2 nmol/dm3). It was found that the length of aliphatic chain on lipophilic acyl moiety also affected to inhibitory effect. Structural analogs of valeroyl derivative and phenylacetyl derivative (N-phenylacetyl-N-{; ; 5-[2-(tetrazole-5- yl)phenyl]thiophen-2-yl}; ; methyl-L-valine) with elongated alkyl chain exhibit lower binding affinity.

Izvorni jezik
Engleski

Znanstvena područja
Kemija, Temeljne medicinske znanosti



POVEZANOST RADA


Projekti:
108-2192382-2369 - Melatonin i angiotenzin II u farmakologiji boli i hipertenzije (Tvrdeić, Ante, MZOS ) ( POIROT)

Ustanove:
Medicinski fakultet, Zagreb

Profili:

Avatar Url Marija Lovrić (autor)

Avatar Url Mladen Litvić (autor)

Avatar Url Ante Tvrdeić (autor)

Avatar Url Ivica Cepanec (autor)


Citiraj ovu publikaciju

Lovrić, Marija; Tvrdeić, Ante; Cepanec, Ivica; Litvić, Mladen
Design, Synthesis and in vitro Activity of AT1 Angiotensin II receptor Antagonists Based on the Novel 5-[2-(tetrazole-5- yl)phenyl]thiophenes // Book of Abstracts 4th Croatian Congress of Neuroscience
Zagreb: Croatian Society for Neuroscience, Croatian Insitute for Brain Research, 2013. str. 73-74 (poster, međunarodna recenzija, sažetak, znanstveni)
Lovrić, M., Tvrdeić, A., Cepanec, I. & Litvić, M. (2013) Design, Synthesis and in vitro Activity of AT1 Angiotensin II receptor Antagonists Based on the Novel 5-[2-(tetrazole-5- yl)phenyl]thiophenes. U: Book of Abstracts 4th Croatian Congress of Neuroscience.
@article{article, year = {2013}, pages = {73-74}, keywords = {angiotensin II (AII) AT1 receptors, 5-[2-(tetrazole-5-yl)phenyl]thiophenes, sartans}, title = {Design, Synthesis and in vitro Activity of AT1 Angiotensin II receptor Antagonists Based on the Novel 5-[2-(tetrazole-5- yl)phenyl]thiophenes}, keyword = {angiotensin II (AII) AT1 receptors, 5-[2-(tetrazole-5-yl)phenyl]thiophenes, sartans}, publisher = {Croatian Society for Neuroscience, Croatian Insitute for Brain Research}, publisherplace = {Zagreb, Hrvatska} }
@article{article, year = {2013}, pages = {73-74}, keywords = {angiotensin II (AII) AT1 receptors, 5-[2-(tetrazole-5-yl)phenyl]thiophenes, sartans}, title = {Design, Synthesis and in vitro Activity of AT1 Angiotensin II receptor Antagonists Based on the Novel 5-[2-(tetrazole-5- yl)phenyl]thiophenes}, keyword = {angiotensin II (AII) AT1 receptors, 5-[2-(tetrazole-5-yl)phenyl]thiophenes, sartans}, publisher = {Croatian Society for Neuroscience, Croatian Insitute for Brain Research}, publisherplace = {Zagreb, Hrvatska} }




Contrast
Increase Font
Decrease Font
Dyslexic Font